alexa Tamer E Fandy | University of Charleston
ISSN: 2153-0645

Journal of Pharmacogenomics & Pharmacoproteomics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Tamer E Fandy

Tamer E Fandy Tamer E. Fandy
Associate Professor
Department of Pharmaceutical & Administrative Sciences
School of Pharmacy
University of Charleston
USA
Read Interview session with Tamer E Fandy
Biography

Dr. Fandy is serving as an assistant professor in the department of pharmaceutical sciences at Albany College of Pharmacy since 2010. After graduation from the school of pharmacy at the University of Southern California with a master degree in 2001, he joined the PhD program in the department of pharmaceutical sciences at the University of Maryland and graduated in 2005. Dr. Fandy Joined the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University as a postdoctoral fellow till 2010. Dr. Fandy is a member of the American Association for Cancer Research and the American Association of Pharmaceutical Scientists and his research focuses on studying the mechanism of action and development of epigenetic modifiers.

Research Interest

Understanding the epigenetic changes associated with tumor initiation and progression is essential for the prevention and treatment of cancer. Changes in DNA methylation and histone modifications have been detected in different types of tumors. Reversal of these changes is associated with tumor arrest and constitutes the basis of epigenetic therapy.  DNA methyltransferase (DNMT) inhibitors and histone deacteylase (HDAC) inhibitors are considered the backbone of epigenetic therapy in cancer and are currently FDA approved for the treatment of myelodysplastic syndrome (MDS) and cutaneous T-cell lymphoma, respectively. My laboratory focuses on understanding the global epigenetic changes associated with DNMT and HDAC inhibitors and the mechanisms of resistance development against these agents.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Epigenetic Therapy in Malignant and Chronic Diseases
Hussein Chahin, Bassey Ekong and Tamer E Fandy
Review Article: J Pharmacogenomics Pharmacoproteomics 2013, 4:2
DOI: 10.4172/2153-0645.1000118
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version